๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Anti-AnWj antibody in a case with non-Hodgkin lymphoma

โœ Scribed by Hiroto Kaneko; Manabu Oki; Kazuho Shimura; Masafumi Taniwaki; Yasuo Ohkawara

Book ID
107618575
Publisher
Carden Jennings Publishing
Year
2008
Tongue
English
Weight
114 KB
Volume
88
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Anti-ebv antibody titers in non-hodgkin
Anti-ebv antibody titers in non-hodgkin lymphomas
โœ A. Liabeuf; N. Feingold; F. M. Kourilsky; J. Dumont; W. Henle ๐Ÿ“‚ Article ๐Ÿ“… 1976 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 808 KB

## Abstract Antibody titers to Epsteinโ€Barr virus (EBV)โ€related antigens, i.e. viral capsid antigen (VCA), the D and R components of the early antigen (EA) complex and the EBVโ€associated nuclear antigen (EBNA), were determined in a series of 86 patients with nonโ€Hodgkin lymphomas and in 150 matched

Treatment of B-cell non-Hodgkin's lympho
Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab
โœ Stefano Sacchi; Massimo Federico; Giuseppe Dastoli; Claudia Fiorani; Giovanni Vi ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 232 KB

Rituximab is a chimeric anti CD-20 monoclonal antibody containing human IgG1 kappa constant regions, with murine variable regions. The anti-lymphoma effects of Rituximab are probably due to complement and antibody-dependent cell-mediated cytotoxicity, and induction of apoptosis. Phase II trials have